Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CD133, a novel marker for human prostatic epithelial stem cells

30 Jun 2004

Abstract excerpt

Stem cells are clonogenic cells with self-renewal and differentiation properties, which may represent a major target for genetic damage leading to prostate cancer and benign prostatic hyperplasia. Stem cells remain poorly characterised because of the absence of specific molecular markers that permit us to distinguish them from their progeny, the transit amplifying cells, which have a more restricted proliferative...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Cells and Metastasis
Share to Immunotherapy and Immune Responses
Share to Prostate Cancer Treatment and Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 15226377
DOI: 10.1242/jcs.01222

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CD133, a novel marker for human prostatic epithelial stem cellsPMID 15226377Read ↗

Expression profiling of CD133<sup>+</sup> and CD133<sup>—</sup> epithelial cells from human prostateSemantic proximity Read ↗

Human Epithelial Basal Cells Are Cells of Origin of Prostate Cancer, Independent of CD133 StatusSemantic proximity Read ↗

Prostate cancer stem/progenitor cells: Identification, characterization, and implicationsSemantic proximity Read ↗

The characterization of epithelial and stromal subsets of candidate stem/progenitor cells in the human adult prostate.Semantic proximity Read ↗

CD44+ CD24(-) prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis.Semantic proximity Read ↗

Therapeutic implications of cancer stem cells in prostate cancerSemantic proximity Read ↗

Role of prostate cancer stem-like cells in the development of antiandrogen resistanceSemantic proximity Read ↗

Cd133: a marker of transit amplification rather than stem cell phenotype in the prostate?Semantic proximity Read ↗

Telomerase-immortalized non-malignant human prostate epithelial cells retain the properties of multipotent stem cells.Semantic proximity Read ↗

Prospective Identification of Tumorigenic Prostate Cancer Stem CellsSemantic proximity Read ↗

A tumour stem cell hypothesis for the origins of prostate cancer.Semantic proximity Read ↗

Prostate cancer as a dedifferentiated organ: androgen receptor, cancer stem cells, and cancer stemnessSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.